Literature DB >> 19950814

Ultrasound guided liver resection: does this approach limit the need for portal vein embolization?

Guido Torzilli1, Matteo Donadon, Angela Palmisano, Matteo Marconi, Fabio Procopio, Florin Botea, Daniele Del Fabbro, Alessandro Cappellani, Marco Montorsi.   

Abstract

BACKGROUND/AIMS: Major hepatectomy is associated with higher risks of morbidity and mortality. Portal vein embolization (PVE) has been advocated to minimize those risks. However, PVE itself has associated drawbacks. The use of ultrasound-guided liver resection minimizes the need for major resection, and might reduce the use of PVE. The aim of this study was to validate this hypothesis.
METHODOLOGY: Two hundred and ninety-eight consecutive patients who underwent liver surgery were reviewed. Eighty-five of these patients with tumors corresponding to right 1st/2nd order portal branches (Zone P) and right hepatic vein (Zone H) were selected as potential candidates for major hepatectomy and PVE. Indications to PVE were based on the most recent reported criteria. Surgical strategy was based on the relationship between the tumor and the intrahepatic vascular structures at intraoperative ultrasonography (IOUS).
RESULTS: Thirty-six (42%) patients with tumors located in Zones H and P were potential candidates to PVE, but none underwent this procedure. Major hepatecomies were performed in 10 (12%) patients. No hospital mortality was seen. Morbidity rate was 19% and major morbidity occurred in 2 patients. Blood transfusion rate was 12%. Mean tumor-free margin was 0.1 cm (median 0.1; range 0-0.6). None had local recurrence after a mean follow-up of 28 months (median 27; range 6-68).
CONCLUSIONS: IOUS guidance allows an alternative, safe, and effective surgical approach for patients generally submitted to major hepatectomy and most of them to preoperative PVE. In this perspective, further studies are required to reassess indications to PVE.

Entities:  

Mesh:

Year:  2009        PMID: 19950814

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Diagnosis and Management of Bile Leaks After Hepatectomy: Results of a Prospective Analysis of 475 Hepatectomies.

Authors:  Matteo Donadon; Guido Costa; Matteo Cimino; Fabio Procopio; Daniele Del Fabbro; Angela Palmisano; Guido Torzilli
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

2.  Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Authors:  Reid B Adams; Thomas A Aloia; Evelyne Loyer; Timothy M Pawlik; Bachir Taouli; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

3.  The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.

Authors:  L Viganò; B Branciforte; V Laurenti; G Costa; F Procopio; M Cimino; D Del Fabbro; L Di Tommaso; G Torzilli
Journal:  Ann Surg Oncol       Date:  2022-06-10       Impact factor: 4.339

Review 4.  Surgery of Colorectal Liver Metastases: Pushing the Limits.

Authors:  Guido Torzilli; René Adam; Luca Viganò; Katsunori Imai; Jeremias Goransky; Andrea Fontana; Christian Toso; Pietro Majno; Eduardo de Santibañes
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

5.  Placement of vein grafting in liver surgery at the time of the R1 vascular concept and the communicating veins.

Authors:  Guido Torzilli
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

6.  Minor-but-Complex Liver Resection: An Alternative to Major Resections for Colorectal Liver Metastases Involving the Hepato-Caval Confluence.

Authors:  Lucio Urbani; Gianluca Masi; Marco Puccini; Piero Colombatto; Caterina Vivaldi; Riccardo Balestri; Antonio Marioni; Valerio Prosperi; Francesco Forfori; Gabriella Licitra; Chiara Leoni; Adriana Paolicchi; Piero Boraschi; Alessandro Lunardi; Carlo Tascini; Maura Castagna; Piero Buccianti
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.